Cancer genetics and their application to individualised medicine

European Journal of Cancer

Volumn 38, Issue 7, 2002, Pages 872-879

  Liefers, G J ^a   Tollenaar, R A E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; FLUOROURACIL; PROTEIN P53;

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RESEARCH; CANCER STAGING; CANCER THERAPY; CHROMOSOME 18Q; COLORECTAL CANCER; DNA MICROARRAY; GENE EXPRESSION; HUMAN; MEDICINE; MICROSATELLITE INSTABILITY; PATIENT CARE; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; TAXONOMY;

ADENOMATOUS POLYPOSIS COLI; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA REPAIR; GENE EXPRESSION; GENE THERAPY; GENES, APC; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036230253     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00055-2     Document Type: Article

References (46)

1. Initial sequencing and analysis of the human genome
2. Shattuck Lecture - Medical and societal consequences of Human Genome Project
3. Genome wide views of cancer
4. A genetic model for colorectal tumorigenesis
5. Lessons from hereditary colorectal cancer
6. The adenomatous polyposis coli (APC) tumor suppressor
7. -/-colon carcinoma
8. Control of beta-catenin signaling in tumor development
9. Beta-catenin mutations in cell lines established from human colorectal cancer
10. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas
11. Mutations in the p53 gene occur in diverse human tumour types
12. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes
13. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis
14. Molecular diagnosis of familial adenomatous polyposis
15. Clinial findings with implications for genetic testing in families with clustering of colorectal cancer
16. Micrometastases and survival in stage II colorectal cancer
17. Fluorouracil plus levamisol as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
18. Molecular predictors of survival after adjuvant chemotherapy for colon cancer
19. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy
20. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
21. Tumour markers of prognosis in colorectal cancer
22. P53 point mutation and survival in colorectal cancer patients
23. Tp53 and long-term prognosis in colorectal cancer - Mutations in 13 zinc-binding domain predict poor survival
24. P53 and K-ras gene mutations correlate with tumor aggressiveness but are not routine prognostic value in colorectal cancer
25. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group study
26. Allelic loss of chromosome 18q and prognosis in colorectal cancer
27. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator
28. Allelic loss on chromosome 18q as prognostic marker in stage II colorectal cancer
29. The DCC protein and prognosis in colorectal cancer
30. Methylation of the hMLH1 promotor correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines
31. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers
32. Involvement of chemokine receptors in breast cancer metastasis
33. Chemokines and the molecular basis of cancer metastasis
34. Complementary DNA sequencing: Expressed sequence tags and Human Genome Project
35. Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA
36. Cluster analysis and display of genome-wide expression patterns
37. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
38. Transcriptional gene expression profiles of colorecal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays
39. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissue and normal epithelia
40. Comparing microarray data: What technology is needed?
41. Genetic cancer syndromes and large scale gene expression analysis: Applications in surgical oncology
42. Genomic analysis of metastases reveals an essential role for RhoC
43. Systematic variation in gene expression patterns in human cancer cell lines
44. A gene expression database for the molecular pharmacology of cancer
45. Inactivation of the DNA-repair gene MGMT and the clinical response to alkylating agents
46. Genetic prognostic markers for colorectal cancer